Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Clemens

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Immunology Letters|March 9, 2005
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNAJan Holmgren, Jenni Adamsson, Fabienne Anjuère, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|June 1, 2005
[Application of cluster randomization method on typhoid Vi vaccine trails]Bai-qing Dong, Jin Yang, Zhen-zhu Tang, et al.
Vaccine|October 25, 2003
Mass psychogenic illness following oral cholera immunization in Ca Mau City, VietnamHa Ba Khiem, Le Dinh Huan, Nguyen Thi Minh Phuong, et al.
Plos Medicine|September 14, 2006
A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiologyLorenz von Seidlein, Deok Ryun Kim, Mohammad Ali, et al.
Tropical Medicine & International Health : TM & IH|July 29, 2014
Typhoid fever in Fiji: a reversible plague?Corinne N Thompson, Mike Kama, Shrish Acharya, et al.
The Lancet. Infectious Diseases|September 8, 2012
Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort studyAhmed M Khatib, Mohammad Ali, Lorenz von Seidlein, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 8, 2020
Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in BangladeshTahmina Shirin, Taufiqur Rahman Bhuiyan, Richelle C Charles, et al.
The Lancet. Global Health|November 19, 2021
Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based studyJames E Meiring, Mila Shakya, Farhana Khanam, et al.
Human Vaccines & Immunotherapeutics|January 27, 2023
Effectiveness of vero cell inactivated vaccine against severe acute respiratory infections (SARI) in Sibu, Malaysia: A retrospective test-negative designTeck-Hock Toh, Yang-Yang Qi, Sook-Min Yong, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2010
Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolonesChristopher M Parry, Chau Tran Thuy, Sabina Dongol, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Immunology Letters|March 9, 2005
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNAJan Holmgren, Jenni Adamsson, Fabienne Anjuère, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|June 1, 2005
[Application of cluster randomization method on typhoid Vi vaccine trails]Bai-qing Dong, Jin Yang, Zhen-zhu Tang, et al.
Vaccine|October 25, 2003
Mass psychogenic illness following oral cholera immunization in Ca Mau City, VietnamHa Ba Khiem, Le Dinh Huan, Nguyen Thi Minh Phuong, et al.
Plos Medicine|September 14, 2006
A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiologyLorenz von Seidlein, Deok Ryun Kim, Mohammad Ali, et al.
Tropical Medicine & International Health : TM & IH|July 29, 2014
Typhoid fever in Fiji: a reversible plague?Corinne N Thompson, Mike Kama, Shrish Acharya, et al.
The Lancet. Infectious Diseases|September 8, 2012
Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort studyAhmed M Khatib, Mohammad Ali, Lorenz von Seidlein, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 8, 2020
Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in BangladeshTahmina Shirin, Taufiqur Rahman Bhuiyan, Richelle C Charles, et al.
The Lancet. Global Health|November 19, 2021
Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based studyJames E Meiring, Mila Shakya, Farhana Khanam, et al.
Human Vaccines & Immunotherapeutics|January 27, 2023
Effectiveness of vero cell inactivated vaccine against severe acute respiratory infections (SARI) in Sibu, Malaysia: A retrospective test-negative designTeck-Hock Toh, Yang-Yang Qi, Sook-Min Yong, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2010
Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolonesChristopher M Parry, Chau Tran Thuy, Sabina Dongol, et al.
Pageof 9